4.03
0.50%
0.02
Handel nachbörslich:
4.02
-0.01
-0.25%
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World
Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa
Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India
CLGN (CollPlant Biotechnologies) 50-Day SMA : $4.31 (As of Dec. 01, 2024) - GuruFocus.com
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call Transcript - MSN
CLGNCollPlant Biotechnologies Ltd Ordinary Shares Latest Stock News & Market Updates - StockTitan
CollPlant Biotechnologies Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highl - GuruFocus.com
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance
CollPlant Biotechnologies’ Q3 2024 Financial Update - TipRanks
Q3 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com
CollPlant Issues Letter to Shareholders - GuruFocus.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings - GuruFocus.com
Collplant stock hits 52-week low at $3.56 amid market challenges - Investing.com Canada
Collplant stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies (CLGN) Set to Announce Earnings on Wednesday - Defense World
CollPlant (CLGN) to Report Q3 2024 Earnings on Nov 27: Conference Call Details | CLGN Stock News - StockTitan
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION – Company AnnouncementFT.com - Financial Times
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PR Newswire
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth - Yahoo Finance
Collplant stock hits 52-week low at $3.61 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com India
Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com Australia
EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN
Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat
Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
CollPlant Shareholders Approve Key Proposals - TipRanks
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN
CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com
The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat
Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World
FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat
HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.
CollPlant Schedules Shareholder Meeting - Investing.com India
CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga
CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):